Constellation Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Constellation Pharmaceuticals generated cash of -$111,424,000, which is less than the previous year. Cash used in financing activities reached the amount of $152,494,000 last year. Net change in cash is therefore -$167,831,000.
Cash Flow
| 2016 | -32.77M | -945K | 19.10M |
|---|---|---|---|
| 2017 | -37.58M | -582K | 17.65M |
| 2018 | -48.82M | -476K | 147.67M |
| 2019 | -72.24M | -49.60M | 341.59M |
| 2020 | -111.42M | -208.90M | 152.49M |
CNST Cash Flow Statement (2016 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|
Cash at beginning of period | 334.75M | 115.01M | 16.64M | 37.16M | 51.77M |
Operating activities | |||||
Net income | -126.35M | -85.55M | -59.92M | -35.37M | -34.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 644K | 758K | 562K | 474K | 203K |
Stock-based compensation expense | 14.78M | 6.91M | 3.95M | 1.15M | 848K |
| Deferred income tax benefit | 14.78M | 6.91M | 3.95M | 1.15M | 848K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.52M | 1.73M | 2.75M | 67K | 423K |
Cash generated by operating activities | -111.42M | -72.24M | -48.82M | -37.58M | -32.77M |
Investing activities | |||||
Purchases Of Investments | -580.33M | -114.68M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -946K | -699K | -476K | -582K | -948K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -208.90M | -49.60M | -476K | -582K | -945K |
Financing activities | |||||
Common Stock Issued | 180.72M | 307.02M | 55.80M | 55K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -32.20M | 0 | -4.69M | 0 | -2.96M |
Cash used in financing activities | 152.49M | 341.59M | 147.67M | 17.65M | 19.10M |
Net Change In Cash | -167.83M | 219.74M | 98.37M | -20.51M | -14.61M |
Cash at end of period | 166.92M | 334.75M | 115.01M | 16.64M | 37.16M |
| Data source | Data source | Data source |